首页> 外文期刊>Epilepsy & behavior: E&B >The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting
【24h】

The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting

机译:与拉莫三嗪和托吡酯相比,在自然主义的门诊患者中,与拉莫三嗪和托吡酯相比,拉考沙胺辅助抗癫痫治疗的长期认知效果

获取原文
获取原文并翻译 | 示例
       

摘要

In this retrospective controlled study, the impact of adjunctive lacosamide (LCM) on cognition in patients with epilepsy was evaluated and compared with that of topiramate (TPM) and lamotrigine (LTG) in a naturalistic outpatient setting. Cognition was investigated by means of objective assessment of executive functions (EpiTrack?) and verbal memory and by subjective ratings of self-perceived side effects (cognition, mood, and vegetative). Quality of life was assessed using the QOLIE-10 questionnaire. Patients underwent assessment at baseline and after a median follow-up interval of 32weeks. Forty-four patients were treated with LCM, 11 with LTG, and 15 with TPM. Treatment arms differed with regard to the age at onset of epilepsy (LTGTPM) and to seizure control from baseline to follow-up, which was best in patients whose seizures were treated with LTG (55% vs. 16% in patients whose seizures were treated with LCM and 13% in patients whose seizures were treated with TPM). Groups did not differ in the type of epilepsy, daily drug load or drug load change, nor in baseline seizure frequency. Repeated measures statistics controlling for epilepsy onset and seizure outcome showed deteriorated executive functions with TPM (F=7.5, p=0.001). On an individual level (reliable change indices), 53% of the patients whose seizures were treated with TPM showed losses in this domain (LCM 14%, LTG 27%) and none of the patients showed improvement (LCM 23%, LTG 27%; χ2=11.8, p=0.019). No differences in memory, quality of life, or mood were noted among patients in the three treatment arms. Subjective cognitive complaints increased in 5 of the 9 patients whose seizures were treated with TPM (LCM 1/9, LTG 0/9; χ2=11.9, p=0.025). The findings of this study demonstrate for the first time that the cognitive side effect profile of LCM is comparable to that of LTG and superior to that of TPM. This is indicated by both subjective and objective measures. Given the naturalistic setting and the retrospective nature of the study, a follow-up prospective, randomized trial with larger sample sizes is required to confirm these findings.
机译:在这项回顾性对照研究中,评估了辅助性拉可酰胺(LCM)对癫痫患者认知的影响,并在自然门诊患者中与托吡酯(TPM)和拉莫三嗪(LTG)进行了比较。通过对执行功能(EpiTrack?)和言语记忆的客观评估以及对自我感知的副作用(认知,情绪和植物性)的主观评价来调查认知。使用QOLIE-10问卷评估生活质量。患者在基线和中位随访期32周后接受评估。 LCM治疗44例,LTG治疗11例,TPM治疗15例。从癫痫发作的开始年龄(LTG> TPM)和从基线到随访的癫痫控制方面,治疗方法各不相同,这在接受LTG治疗的癫痫患者中最好(55%对16%的癫痫患者)癫痫发作使用LCM进行治疗,癫痫发作采用TPM进行治疗的患者占13%)。各组在癫痫类型,每日药物负荷或药物负荷变化,基线发作频率上均无差异。控制癫痫发作和癫痫发作结果的重复测量统计数据显示,TPM使执行功能恶化(F = 7.5,p = 0.001)。在个体水平(可靠的变化指数)上,接受TPM治疗的癫痫患者中有53%在该范围内表现出丧失(LCM 14%,LTG 27%),没有患者表现出改善(LCM 23%,LTG 27%) ;χ2= 11.8,p = 0.019)。在三个治疗组中,患者的记忆力,生活质量或情绪没有差异。用TPM治疗的9例癫痫发作患者中,有5例主观认知障碍增加(LCM 1/9,LTG 0/9;χ2= 11.9,p = 0.025)。这项研究的发现首次证明LCM的认知副作用与LTG相当,并且优于TPM。主观和客观测量都表明了这一点。考虑到研究的自然背景和回顾性,需要进行后续的前瞻性,大样本量的随机试验以证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号